XML 82 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2013
Dec. 31, 2012
Assets:    
Cash $ 156,797 $ 108,619
Securities available-for-sale, at estimated fair value 52,909 67,079
Securities, at estimated fair value 184,208 211,809
Commercial mortgage loans, held for investment 143,492 142,921
Subordinate loans, held for investment 354,865 246,246
Repurchase agreements, held for investment    6,598
Interest receivable 4,830 4,277
Deferred financing costs, net 1,018 678
Other assets    203
Total Assets 898,119 788,430
Liabilities:    
Borrowings under repurchase agreements 191,312 225,158
Derivative instruments, net 25 155
Accounts payable and accrued expenses 1,367 1,265
Payable to related party 2,600 2,037
Dividends payable 16,821 12,891
Total Liabilities 212,125 241,506
Commitments and Contingencies (see Note 13)      
Stockholders’ Equity:    
Preferred stock, $0.01 par value, 50,000,000 shares authorized and 3,450,000 shares issued and outstanding in 2013 and 2012 35 35
Common stock, $0.01 par value, 450,000,000 shares authorized, 36,880,410 and 28,044,106 shares issued and outstanding in 2013 and 2012, respectively 369 280
Additional paid-in-capital 695,572 546,065
Retained earnings (accumulated deficit) (9,320) 574
Accumulated other comprehensive loss (662) (30)
Total Stockholders’ Equity 685,994 546,924
Total Liabilities and Stockholders’ Equity $ 898,119 $ 788,430